Notice of Change to Key Dates for RFA-NS-22-021 "HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)"
Notice Number:
NOT-NS-23-034

Key Dates

Release Date:

October 12, 2022

Related Announcements

RFA-NS-22-021 - HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to extend RFA-NS-22-021 "HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)" by one council round. The new, resubmission, and revision application due date is March 9, 2023. The new expiration date is March 10, 2023. Changes to the Funding Opportunity Announcement (FOA) are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates:

New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
March 17, 2022
March 17, 2022
Not Applicable July 2022
October 2022
December 2022
October 11, 2022 October 11, 2022 Not Applicable March 2023
May 2023
July 2023

Expiration Date: October 12, 2022

Modified to Read:

Part 1. Overview Information

Key Dates:

New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
March 17, 2022
March 17, 2022
Not Applicable July 2022
October 2022
December 2022
October 11, 2022 October 11, 2022 Not Applicable March 2023
May 2023
July 2023
March 9, 2023 March 9, 2023 Not Applicable July 2023 October 2023 December 2023

Expiration Date: March 10, 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Julia L. Bachman, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-827-7383
Email: julia.bachman@nih.gov